Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3057% below fair value
$10.56+0.20 (+1.93%)
Close on Nov 16, 2026Market cap $185.81MP/E 10.5Yield –
Natures Sunshine Products ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Natures Sunshine Products's ebitda for the twelve months ending Jun 30, 2026 was $42.69M, up 22.5% year over year. For fiscal 2025 it was $38.59M, up 12.5% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $45.83M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.59M | +12.5% |
| FY2024 | Dec 31, 2024 | $34.31M | +12.3% |
| FY2023 | Dec 31, 2023 | $30.57M | +12.0% |
| FY2022 | Dec 31, 2022 | $27.28M | -40.5% |
| FY2021 | Dec 31, 2021 | $45.83M | +42.2% |
| FY2020 | Dec 31, 2020 | $32.23M | +20.6% |
| FY2019 | Dec 31, 2019 | $26.72M | +76.3% |
| FY2018 | Dec 31, 2018 | $15.16M | +51.3% |
| FY2017 | Dec 31, 2017 | $10.02M | -32.5% |
| FY2016 | Dec 31, 2016 | $14.85M | -19.3% |
| FY2015 | Dec 31, 2015 | $18.40M | -21.6% |
| FY2014 | Dec 31, 2014 | $23.46M | -16.4% |
| FY2013 | Dec 31, 2013 | $28.05M | -26.1% |
| FY2012 | Dec 31, 2012 | $37.94M | +54.7% |
| FY2011 | Dec 31, 2011 | $24.53M | +58.1% |
| FY2010 | Dec 31, 2010 | $15.52M | -8.4% |
| FY2009 | Dec 31, 2009 | $16.93M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.78M | +13.0% |
| Q1 FY2026 | Mar 31, 2026 | $12.77M | +32.0% |
| Q4 FY2025 | Dec 31, 2025 | $8.63M | +0.6% |
| Q3 FY2025 | Sep 30, 2025 | $12.51M | +41.9% |
| Q2 FY2025 | Jun 30, 2025 | $7.77M | -14.9% |
| Q1 FY2025 | Mar 31, 2025 | $9.67M | +24.2% |
| Q4 FY2024 | Dec 31, 2024 | $8.57M | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.82M | -1.5% |
| Q2 FY2024 | Jun 30, 2024 | $9.14M | -7.4% |
| Q1 FY2024 | Mar 31, 2024 | $7.78M | +161.5% |
| Q4 FY2023 | Dec 31, 2023 | $8.76M | +23.5% |
| Q3 FY2023 | Sep 30, 2023 | $8.96M | +16.7% |
| Q2 FY2023 | Jun 30, 2023 | $9.87M | +16.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.98M | -26.9% |
| Q4 FY2022 | Dec 31, 2022 | $7.10M | -32.0% |
| Q3 FY2022 | Sep 30, 2022 | $7.67M | -39.8% |
| Q2 FY2022 | Jun 30, 2022 | $8.44M | -31.3% |
| Q1 FY2022 | Mar 31, 2022 | $4.08M | -60.7% |
| Q4 FY2021 | Dec 31, 2021 | $10.43M | +102.2% |
| Q3 FY2021 | Sep 30, 2021 | $12.74M | +54.7% |
| Q2 FY2021 | Jun 30, 2021 | $12.29M | +35.5% |
| Q1 FY2021 | Mar 31, 2021 | $10.37M | +6.2% |
| Q4 FY2020 | Dec 31, 2020 | $5.16M | -26.0% |
| Q3 FY2020 | Sep 30, 2020 | $8.24M | +13.6% |
| Q2 FY2020 | Jun 30, 2020 | $9.07M | +29.0% |
| Q1 FY2020 | Mar 31, 2020 | $9.76M | +78.4% |
| Q4 FY2019 | Dec 31, 2019 | $6.97M | +451.7% |
| Q3 FY2019 | Sep 30, 2019 | $7.25M | +24.6% |
| Q2 FY2019 | Jun 30, 2019 | $7.03M | +52.9% |
| Q1 FY2019 | Mar 31, 2019 | $5.47M | +57.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.26M | – |
| Q3 FY2018 | Sep 30, 2018 | $5.81M | +26.3% |
| Q2 FY2018 | Jun 30, 2018 | $4.60M | +113.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.48M | -0.6% |
| Q4 FY2017 | Dec 31, 2017 | -$243.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $4.61M | -26.6% |
| Q2 FY2017 | Jun 30, 2017 | $2.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.50M | – |
| Q4 FY2016 | Dec 31, 2016 | -$189.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $6.27M | – |
See a number that looks wrong?